Abstract | CONTEXT: OBJECTIVE: DESIGN: We studied 14 lean adolescents [four females; 15.9 ± 1.6 years of age; body mass index (BMI), 21.8 ± 2.2 kg/m2] and 23 adolescents with obesity (five females; 15.1 ± 1.6 years of age; BMI, 34.5 ± 4.6 kg/m2). Participants underwent a baseline oral glucose tolerance test to determine their glucose tolerance and estimate insulin sensitivity and β-cell function [oral disposition index (oDIcpep)]. Eligible subjects received, in a double-blind, crossover design, 75 g of glucose or fructose. Plasma was obtained every 10 minutes for 60 minutes for the measures of glucose, insulin, and GLP-1 (radioimmunoassay) and glucose-dependent insulinotropic polypeptide (GIP; ELISA). Incremental glucose and hormone levels were compared between lean individuals and those with obesity by a linear mixed model. The relationship between GLP-1 increment and oDIcpep was evaluated by regression analysis. RESULTS: Following the fructose challenge, plasma glucose excursions were similar in both groups, yet the adolescents with obesity exhibited a greater insulin (P < 0.001) and GLP-1 (P < 0.001) increase than did their lean peers. Changes in GIP were similar in both groups. After glucose ingestion, the GLP-1 response (P < 0.001) was higher in the lean group. The GLP-1 increment during 60 minutes from fructose drink was correlated with a lower oDIcpep (r2 = 0.22, P = 0.009). CONCLUSION:
|
Authors | Alfonso Galderisi, Cosimo Giannini, Michelle Van Name, Sonia Caprio |
Journal | The Journal of clinical endocrinology and metabolism
(J Clin Endocrinol Metab)
Vol. 104
Issue 8
Pg. 3481-3490
(08 01 2019)
ISSN: 1945-7197 [Electronic] United States |
PMID | 30938760
(Publication Type: Journal Article, Randomized Controlled Trial, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2019 Endocrine Society. |
Chemical References |
- Insulin
- Sweetening Agents
- Fructose
- Gastric Inhibitory Polypeptide
- Glucagon-Like Peptide 1
- Glucose
|
Topics |
- Adolescent
- Body Mass Index
- Cross-Over Studies
- Double-Blind Method
- Eating
(physiology)
- Female
- Fructose
(adverse effects)
- Gastric Inhibitory Polypeptide
(blood)
- Glucagon-Like Peptide 1
(blood)
- Glucose
(adverse effects)
- Glucose Tolerance Test
- Humans
- Hyperinsulinism
(etiology)
- Insulin
(blood)
- Male
- Pediatric Obesity
(blood, complications, physiopathology)
- Postprandial Period
- Sweetening Agents
(adverse effects)
|